Anonymous - Comment

Document ID: FDA-2006-P-0033-0059
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: October 24 2011, at 12:00 AM Eastern Daylight Time
Date Posted: November 4 2011, at 12:00 AM Eastern Standard Time
Comment Start Date: August 11 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: October 25 2011, at 11:59 PM Eastern Standard Time
Tracking Number: 80f5a667
View Document:  View as format xml

View Comment

The European Union is currently reviewing the draft regulation notified under G/TBT/N/USA/606/Add.1, and Federal Register notice at http://www.gpo.gov/fdsys/pkg/FR-2011-08-11/html/2011-20406.htm. The final date for providing comments on the notification is October, 25 2011. The European Communities are requesting that the comment deadline date be extended to November 25, 2011. Please do not hesitate to communicate with me if you have any questions. EU-WTO-TBT Enquiry Point European Commission Entreprise and Industry Directorate-General, unit C/3 e-mail: eu-tbt@ec.europa.eu tel: 50862 TBT-Europa website: http://ec.europa.eu/enterprise/tbt/

Related Comments

    View All
Total: 9
Wayne Joseph Spaulding - Comment
Public Submission    Posted: 09/21/2011     ID: FDA-2006-P-0033-0056

Oct 25,2011 11:59 PM ET
ProCaps Laboratories - Comment
Public Submission    Posted: 09/21/2011     ID: FDA-2006-P-0033-0057

Oct 25,2011 11:59 PM ET
Anonymous - Comment
Public Submission    Posted: 11/04/2011     ID: FDA-2006-P-0033-0059

Oct 25,2011 11:59 PM ET
Pfizer Consumer Healthcare - Comment
Public Submission    Posted: 11/04/2011     ID: FDA-2006-P-0033-0060

Oct 25,2011 11:59 PM ET
Bettina LICHDI-BALLESTEROS - Comment
Public Submission    Posted: 11/04/2011     ID: FDA-2006-P-0033-0061

Oct 25,2011 11:59 PM ET